IMIC

Experienced medical and professional executives that have had the opportunity of managing multiple activities in the medical industry in Mexico and the U.S. integrate IMIC’s management group. Their goal is to develop a unique clinical research entity in Mexico with the best local and international industry standards.

Adolfo Dorenbaum, BSBA (Chief Financial Officer)

Born in México, obtained his BSBA from the Boston University, Boston, MA. He has spent many years as a consultant setting up new ventures in Mexico City. He has extensive experience in operations and financial management. He has participated in the public administration privatization process, instrumental for the modernization of Mexican economy. Presently, he is responsible for IMIC's legal and financial related activities.

Gina Gorodezky, MD (Chief Medical Officer)

Dr. Gorodezky obtained her Medical Doctor degree from the Universidad Nacional Autonoma de Mexico. Was trained at M.D. Anderson Research Cancer Center as a Hemato/oncologist. She has worked at the Cancer Institute in Mexico City and at the Mexican Cardiology Institute. She has participated in multiple clinical research studies in Mexico, USA., United Kingdom and European Union.

Marc D. Russo, (Business Development / Chief Technical Officer)

Mr. Russo is an experienced entrepreneur, with a background of business set-up, organization, and coordination in diverse commercial ambiences. He entered the Clinical Research environment through one of his areas of expertise, computer networks, website design and software, and rapidly joined IMIC’s marketing and representation area. He has designed IMIC’s company image, including its web page, in addition to representing the Institute in business P-R.

Table of Organization

Research Staff

Mexico City, with the largest medical community in the country, has experienced physicians with backgrounds in clinical research in most therapeutic areas. Although, clinical research in Mexico has not been fully developed as in another countries in the American continent or Europe. However, IMIC, with its experienced research staff. has created a network of experienced investigators that have received adequate training on ICH, GCP, and Local regulations to conduct clinical trials. In addition, IMIC has established very demanding standards for the investigators and sub-investigators that it includes in its specialist database, and trains them in GCP and ICH, also. Therefore, IMIC's investigator database will allow us to select qualified and trained investigators to participate in any therapeutic area study.

Study Coordinators

The study coordinators are the key players in every study that is conducted in IMIC. Therefore, IMIC has developed ongoing training programs in order to maintain all study coordinators fully aware of the ICH and GCP guidelines, and the Mexican regulations. In addition, the study coordinator is responsible for the reviewing of all study specifics, maintain the communication with the study team and the sponsor’s designated personnel, and maintain all study events and records in compliance with the study protocol and regulations.

Bioethics Committee

IMIC is supported by the first independent IRB in Mexico, which is composed by renowned members of the Mexican medical and non-medical community. The IRB conducts the review and approval according to their policies and procedures, the study protocol, the Mexican regulations, and the ICH and GCP guidelines.

Quality Systems

IMIC applies all principles of quality through its Quality Assurance department, which has developed controls that monitor the effectiveness of the systems and processes, and verifies the compliance with the study protocol and regulatory requirements. This department also periodically reviews, measures, identifies any deviations, and implements corrective actions for the continuous improvement of performance.